NexLife compounded semaglutide, per-month prices: standard as of November 6, 2026; microdose as of November 8, 2026; ODT unchanged since our October 15, 2026 read
ProtocolMonth to month3 months6 months12 months12-month plan, year total
Standard injection$109$105$99$95$1,140
Microdose (Nov 8, 2026)$109$105$99$95$1,140
Sublingual ODT$199$185$177$165$1,980

NexLife sells compounded semaglutide as a weekly injection, a microdose protocol and an orally dissolving tablet (ODT). The standard injection changed price on November 6, 2026, and the microdose plans were set to the same prices on November 8; the ODT did not change.

What do you get with NexLife's standard semaglutide?

One monthly price that covers provider review and medical guidance from NexLife Medical Group, a nutrition plan, a 1:1 coaching call, 24/7 support and free expedited shipping. The plan pages say the price is the same at every dose and that there are no memberships or contracts. Lab work is not listed as included.

On October 15, 2026 the standard plans were $139, $132, $125 and $119 a month. As of November 6 they are $109, $105, $99 and $95, so a 12-month plan fell from 12 × $119 = $1,428 to 12 × $95 = $1,140.

Microdose semaglutide price

As of November 8, 2026, NexLife's microdose semaglutide page lists $109 month to month and $105, $99 or $95 a month on 3-, 6- or 12-month plans, the same as the standard plan; a 12-month plan comes to 12 × $95 = $1,140. On our October 15, 2026 read the figures disagreed across NexLife's pages (tiles $165 down to $145, a $129 headline and two FAQ ladders), so older figures are out of date.

Sublingual ODT

The ODT runs $199 month to month and $165 a month on 12 months. It is a compounded tablet, not the Wegovy pill, which is an FDA-approved oral semaglutide made by Novo Nordisk. The STEP trials behind the Wegovy pen tested weekly injections.

How does NexLife compare with Wegovy's self-pay prices?

Wegovy costs more, though the gap is smaller than with Zepbound. NovoCare lists the Wegovy pen at $349 for any dose from 0.25 mg to 2.4 mg, with new patients able to buy two fills of 0.25 mg or 0.5 mg at $199 through December 31, 2026; Wegovy HD 7.2 mg is $399. The Wegovy pill is $149 at 1.5 mg, $199 at 4 mg and $299 at 9 mg and 25 mg.

Arithmetic: one year of semaglutide. Wegovy at NovoCare self-pay prices read November 8, 2026 (pen fills assumed to last 28 days, tablet fills 30 days); NexLife as of November 6, 2026 (12 calendar months)
OptionBasisYear total
Wegovy pen, new-patient offer2 fills at $199, then 11 at $349 (364 days)2 × $199 + 11 × $349 = $4,237
Wegovy pen, no offer13 fills at $349 (364 days)13 × $349 = $4,537
Wegovy HD 7.2 mg13 fills at $39913 × $399 = $5,187
Wegovy pill, label schedule$149, $199, then 10 fills at $299 (360 days)$149 + $199 + 10 × $299 = $3,338
NexLife, month to month12 months at $10912 × $109 = $1,308
NexLife, 12-month plan12 months at $9512 × $95 = $1,140

The pill row follows the Wegovy label's schedule of 1.5 mg, 4 mg and 9 mg for 30 days each before the 25 mg maintenance dose. The NovoCare introductory offer ends December 31, 2026. Wegovy is FDA-approved; compounded semaglutide is made with the drug in Wegovy but is not the same product. Eligible Medicare Part D enrollees can get Wegovy for a $50 copay through the GLP-1 Bridge until December 31, 2027; people with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease are not eligible for the Bridge, though their Part D plan might cover a GLP-1. Our Wegovy page has the detail.

How does NexLife compare with other tracked semaglutide programs?

Two programs print lower standing month-to-month prices, both read October 15, 2026:

Collective prints $59 a month plus a $199 yearly membership, about $76 a month all-in, or 12 × $59 + $199 = $907 a year. Lower stickers from SnagRx, WellMedr, Embody and NextMeds depend on a sale, a prepaid term or an "as low as" figure.

Across the 23 compounded semaglutide programs with a computable all-in figure, the median lowest monthly figure was $99. NexLife's lowest printed figure, $95, is just under it; its $109 month-to-month price is above it. Read dates are mixed, November 6, 2026 for NexLife and October 15, 2026 for nearly every other program, so treat the comparison as a snapshot and check each program's current page before you decide.

What do the trials show, and do they apply?

They describe Wegovy, not compounded semaglutide. In STEP-1, semaglutide 2.4 mg produced a 14.9% mean reduction in body weight at 68 weeks against 2.4% with placebo. In SURMOUNT-5, semaglutide produced 13.7% against 20.2% for tirzepatide at 72 weeks. Both used Novo Nordisk's manufactured injections under trial conditions, so the results do not transfer to NexLife's product, its microdose protocol or its tablet. Our STEP trial summary has more.

The Wegovy label carries a boxed warning about thyroid C-cell tumors and a contraindication for people with a personal or family history of medullary thyroid carcinoma or with MEN 2. Raise both with your prescriber whichever product you use.

Who is NexLife semaglutide a fit for?

If you are weighing the two molecules, see semaglutide vs tirzepatide and our NexLife tirzepatide review. Before ordering from any compounder, use the compounded semaglutide safety checklist.

Frequently asked questions

Is NexLife semaglutide the same as Wegovy?

No. NexLife sells compounded semaglutide, prepared by state-licensed 503A pharmacies with the drug in Wegovy but not the same product. It is not FDA-approved, and FDA does not review compounded GLP-1s for safety, effectiveness or quality before sale. The STEP trial results belong to Wegovy itself. If you want the approved product, NovoCare's self-pay pen price was $349 on our November 8, 2026 read.

What does NexLife microdose semaglutide cost?

As of November 8, 2026, NexLife's microdose semaglutide page lists $109 month to month and $105, $99 or $95 a month on 3-, 6- or 12-month plans, the same as the standard plan. On our October 15, 2026 read the figures conflicted across NexLife's pages, ranging from $165 down to $109, so check the checkout total against these prices.

How does NexLife's semaglutide price compare with other tracked programs?

Price check on first-party reads of November 20, 2026: Mondae charged $87 for one month, Eden Health $99 every month with no membership fee, and Collective $59 plus a $199 yearly membership ($75.58 a month all-in), against NexLife's $109 month to month, dated November 6, 2026. Mondae's 6-month rate was $69 a month and NexLife's 12-month rate $95. Several sale or prepaid offers print lower stickers with conditions.

Is NexLife's 12-month semaglutide plan cheaper than Eden Health over a year?

Slightly, as arithmetic. Twelve months on NexLife's 12-month plan come to $1,140 at $95 a month, while twelve months at Eden Health's $99 come to $1,188, a $48 difference. Month to month, Eden is lower: $99 against NexLife's $109. Mondae's two 6-month prepayments, at $414 each, come to $828 for the year, below both.

Is NexLife's sublingual semaglutide the same as the Wegovy pill?

No. NexLife's sublingual ODT is a compounded, orally dissolving tablet priced from $199 month to month down to $165 a month on 12 months. The Wegovy pill is Novo Nordisk's FDA-approved oral semaglutide, priced by NovoCare at $149 for 1.5 mg, $199 for 4 mg and $299 for 9 mg and 25 mg. They are different products with different evidence behind them.

Does NexLife charge more as the semaglutide dose goes up?

Not on the standard plans. NexLife's plan pages say the price is the same at every dose, so a 12-month plan is $95 a month at any dose. Wegovy's pen is also flat at $349 across 0.25 mg to 2.4 mg, but Wegovy HD 7.2 mg is $399 and the pill rises from $149 to $299 as the dose climbs.

Sources

  1. NexLife: Compounded semaglutide, all plans — prices as of 2026-11-06; inclusions and terms read 2026-10-15
  2. NexLife: Microdose semaglutide program — microdose prices read 2026-11-08 (equal to the standard plans); conflicting figures on 2026-10-15
  3. NexLife: Sublingual semaglutide ODT — read 2026-10-15; unchanged as of 2026-11-06
  4. NexLife: Frequently asked questions — site-wide microdose ladder read 2026-10-15
  5. NovoCare: Wegovy savings offer and self-pay prices — pen, HD and pill prices and new-patient offer read 2026-11-08
  6. FDA label (DailyMed): Wegovy injection and tablets prescribing information — label revised 06/2026; tablet schedule, boxed warning and contraindications read for this site 2026-11-08
  7. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1), N Engl J Med — published 2021 (N Engl J Med 384:989-1002)
  8. Aronne LJ et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5), N Engl J Med — published 2025
  9. CMS: Medicare GLP-1 Bridge — $50 copay, July 1, 2026 to December 31, 2027; read 2026-10-15
  10. Mondae: Compounded semaglutide — first read 2026-10-15
  11. Eden Health: GLP-1 treatments — $99 every month, no membership fees; read 2026-10-15

Comparing programs? Check the all-in monthly price, the named pharmacy and the cancellation terms on the provider's own page before you pay.

Check NexLife's plans and state availability → See the price index

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.